Neuroscience

Personal View looks back on 40 years of the Glasgow Coma Scale

A group of leading brain injury specialists look back on 40 years of the Glasgow Coma Scale and outline the continuing role of the scale in research and clinical practice, in a new Personal View published in The Lancet Neurology.

Neuroscience

Gel reduced daily tremors in Parkinson's disease

(Medical Xpress)—An experimental treatment for Parkinson's disease reduced by nearly two hours on average the period each day when medication failed to control patients' slowness and shaking, according to results from a ...

Alzheimer's disease & dementia

Alzheimer's progression tracked prior to dementia

For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can last a decade ...

Alzheimer's disease & dementia

Bolstering your brain against dementia

For years, the news about Alzheimer's and other dementia-related illness has been unrelentingly grim. We don't know many of the causes. We don't have a cure.

Neuroscience

Cannabis constituent has no effect on MS progression, study shows

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that ...

Neuroscience

Study puts Huntington's disease trials on TRACK

(Medical Xpress)—A three-year multinational study has tracked and detailed the progression of Huntington's disease (HD), predicting clinical decline in people carrying the HD gene more than 10 years before the expected ...

page 3 from 8